Cinemark (CNK) Form 144 Filed for 7,200-Share Sale on Aug 15, 2025

Rhea-AI Filing Summary

Cinemark Holdings, Inc. (CNK) Form 144 filing for proposed sale of shares by an insider. The filing shows a proposed sale of 7,200 common shares through Charles Schwab & Co., Inc. on 08/15/2025, with an aggregate market value of $181,246.00 and total shares outstanding listed as 115,035,514. The securities were acquired via restricted stock lapses: 3,309 shares on 02/23/2023 and 3,891 shares on 02/20/2024, both identified as equity compensation from Cinemark Holdings, Inc. The filer previously sold 7,200 shares on 05/15/2025 yielding $226,340.00. The notice includes the signer’s representation about lack of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insiders are selling limited equity-compensation shares; transactions appear routine and disclosed under Rule 144.

The filing documents a notice of proposed sale under Rule 144 for 7,200 common shares to be executed through Charles Schwab on 08/15/2025. All shares offered derive from restricted stock lapses granted as equity compensation in 2023 and 2024, which is consistent with typical post-vesting dispositions by insiders. The filing also reports a prior sale of 7,200 shares on 05/15/2025 generating $226,340.00 in gross proceeds. No additional context on intent, larger disposition plans, or material nonpublic information is provided in the form.

Corporate Governance Expert

TL;DR: Governance disclosure standards met; representation about material nonpublic information is included.

The Form 144 supplies required transaction-level details: acquisition dates, nature of acquisition (restricted stock lapse), broker, and amounts. The signer affirms absence of undisclosed material adverse information and the form references Rule 10b5-1 considerations, though no 10b5-1 plan date is provided. The disclosure aligns with routine compliance for insider sales but provides no indication of strategic corporate or governance changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	7200	181246.00	115035514	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2023	Restricted Stock Lapse	Cinemark Holdings, Inc.			3309	02/23/2023	Equity Compensation
Common	02/20/2024	Restricted Stock Lapse	Cinemark Holdings, Inc.			3891	02/20/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MELISSA THOMAS 3900 DALLAS PARKWAY PLANO TX 75093	Cinemark Holdings, Inc.	05/15/2025	7200	226340.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)